Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?

C Hayton
, Christopher Craig
, N Chaudhuri

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	339-340
Number of pages	2
Journal	Journal of thoracic disease
DOIs	https://doi.org/10.21037/jtd.2018.12.33
Publication status	Published (in print/issue) - 26 Feb 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/jtd.2018.12.33

Other files and links

Cite this

@article{3f92b8002b1f42ab82d4316457e22d27,

title = "Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?",

author = "C Hayton and Christopher Craig and N Chaudhuri",

year = "2019",

month = feb,

day = "26",

doi = "10.21037/jtd.2018.12.33",

language = "English",

pages = "339--340",

journal = "Journal of thoracic disease",

issn = "2077-6624",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?

AU - Hayton, C

AU - Craig, Christopher

AU - Chaudhuri, N

PY - 2019/2/26

Y1 - 2019/2/26

UR - http://europepmc.org/abstract/med/30962967

UR - https://www.scopus.com/pages/publications/85070554700

U2 - 10.21037/jtd.2018.12.33

DO - 10.21037/jtd.2018.12.33

M3 - Review article

C2 - 30962967

SN - 2077-6624

SP - 339

EP - 340

JO - Journal of thoracic disease

JF - Journal of thoracic disease

ER -